Asia
Pfizer acquired China/Asia rights for Cresemba, an antifungal drug developed by Swiss pharma Basilea, in a $226M deal.
Esaote S.p.A., an Italian medical imaging company, has been acquired by a group of China investors.
Teva may be passing out more pink slips as the company looks to cut up to 10,000 jobs in order to save up to $2B in costs over the next two years.
Completed in two stages, the plant has begun operating fourteen 2,000 liter disposable bioreactors for fed-batch cell culture in the facility.
With the latest funding, Genova has raised $200M in capital.
The investigation dates back to a probe launched in May by Israel’s version of the U.S. SEC though the subject matter of the investigation was not initially revealed.
The results demonstrate that the combination of BL-8040 with HiDAC in this difficult-to-treat patient population significantly improved overall survival, compared with historical data of HiDAC monotherapy.
12 Sigma Technologies, a San Diego medical imaging firm founded by a team of Chinese scientists, raised $30M in a B round led by China VC firm SBCVC.
Although GenomiCare did not disclose the size of the A round, the company did say it has raised $25M since its inception in 2015.
PRESS RELEASES